{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:20:10Z","timestamp":1791404410902,"version":"4.3.3"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601600"],"award-info":[{"award-number":["81601600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701763"],"award-info":[{"award-number":["81701763"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571768"],"award-info":[{"award-number":["81571768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M590576"],"award-info":[{"award-number":["2016M590576"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2017M612098"],"award-info":[{"award-number":["2017M612098"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biomaterials.2018.08.013","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T11:32:36Z","timestamp":1533382356000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin"],"prefix":"10.1016","volume":"182","author":[{"given":"Lili","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renquan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bensheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biomaterials.2018.08.013_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nano.2014.11.006","article-title":"Recent advances in targeted nanoparticles drug delivery to melanoma","volume":"11","author":"Li","year":"2015","journal-title":"Nanomed-Nanotechnol"},{"issue":"7","key":"10.1016\/j.biomaterials.2018.08.013_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/onc.2017.391","article-title":"Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition","volume":"37","author":"Dietrich","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biomaterials.2018.08.013_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/fon.14.252","article-title":"Vemurafenib for the treatment of BRAF mutant metastatic melanoma","volume":"11","author":"Martin-Liberal","year":"2015","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.08.013_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/nn405383a","article-title":"Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer","volume":"8","author":"Jung","year":"2014","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.biomaterials.2018.08.013_bib5","article-title":"Imiquimod enhances the effect of cryotherapy in the management of cutaneous melanoma metastases: a retrospective study of 20 patients","volume":"72","author":"Tolosa","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biomaterials.2018.08.013_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-10-23","article-title":"Therapy for metastatic melanoma: the past, present, and future","volume":"10","author":"Finn","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.biomaterials.2018.08.013_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canlet.2017.03.037","article-title":"Research progress in advanced melanoma","volume":"397","author":"Luo","year":"2017","journal-title":"Cancer Lett"},{"issue":"35","key":"10.1016\/j.biomaterials.2018.08.013_bib8","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1200\/JCO.2008.17.5448","volume":"26","author":"Atkins","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.08.013_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biotechadv.2016.01.004","article-title":"Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy","volume":"34","author":"Brys","year":"2016","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.08.013_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/CCO.0b013e32833888ee","article-title":"Mutation-driven drug development in melanoma","volume":"22","author":"Flaherty","year":"2010","journal-title":"Curr. Opin. Oncol."},{"issue":"11","key":"10.1016\/j.biomaterials.2018.08.013_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrd3847","article-title":"Vemurafenib: the first drug approved for BRAF-mutant cancer","volume":"11","author":"Bollag","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2018.08.013_bib12","article-title":"ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma","volume":"9","author":"Han","year":"2018","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.biomaterials.2018.08.013_bib13","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2018.08.013_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-Mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.08.013_bib15","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.ejca.2013.01.015","volume":"49","author":"Dias","year":"2013","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.biomaterials.2018.08.013_bib16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jid.2013.6","article-title":"Vemurafenib induces senescence features in melanoma cells","volume":"133","author":"Haferkamp","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.08.013_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.7150\/thno.18238","article-title":"Design and development of fluorescent vemurafenib analogs for in vivo imaging","volume":"7","author":"Mikula","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biomaterials.2018.08.013_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/hep.28692","article-title":"Vemurafenib-induced granulomatous hepatitis","volume":"65","author":"Spengler","year":"2017","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.biomaterials.2018.08.013_bib19","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.28709","article-title":"Acute renal failure associated with the new BRAF inhibitor vemurafenib","volume":"120","author":"Launay-Vacher","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2018.08.013_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-3659(96)01567-2","article-title":"Percutaneous absorption: a multiple pathway model","volume":"45","author":"Lee","year":"1997","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2018.08.013_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nbt928","article-title":"Discovery of transdermal penetration enhancers by high-throughput screening","volume":"22","author":"Karande","year":"2004","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.08.013_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt1193","article-title":"Transdermal protein delivery by a coadministered peptide identified via phage display","volume":"24","author":"Chen","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.08.013_bib23","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/7\/4\/045001","article-title":"Microstereolithography and characterization of poly(propylene fumarate)-based drug-loaded microneedle arrays","volume":"7","author":"Lu","year":"2015","journal-title":"Biofabrication"},{"issue":"34","key":"10.1016\/j.biomaterials.2018.08.013_bib24","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1016\/j.biomaterials.2010.08.046","article-title":"Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery","volume":"31","author":"Huang","year":"2010","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2018.08.013_bib25","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1007\/s11095-014-1436-x","article-title":"Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy","volume":"31","author":"Savla","year":"2014","journal-title":"Pharm Res-Dordr"},{"key":"10.1016\/j.biomaterials.2018.08.013_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.colsurfb.2014.02.036","article-title":"Storage stability and skin permeation of vitamin C liposomes improved by pectin coating","volume":"117","author":"Zhou","year":"2014","journal-title":"Colloids Surf., B"},{"issue":"2","key":"10.1016\/j.biomaterials.2018.08.013_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1021\/acsami.6b13738","article-title":"Coadministration of oligomeric hyaluronic acid-modified liposomes with tumor-penetrating peptide-iRGD enhances the antitumor efficacy of doxorubicin against melanoma","volume":"9","author":"Deng","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2018.08.013_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biomaterials.2017.06.034","article-title":"Sensitivity to antitubulin chemotherapeutics is potentiated by a photoactivable nanoliposome","volume":"141","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2018.08.013_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1039\/C5BM00433K","article-title":"The next generation cell-penetrating peptide and carbon dot conjugated nano-liposome for transdermal delivery of curcumin","volume":"4","author":"Patra","year":"2016","journal-title":"Biomater Sci-Uk"},{"issue":"8","key":"10.1016\/j.biomaterials.2018.08.013_bib30","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.nano.2016.07.001","article-title":"Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles","volume":"12","author":"Bernardi","year":"2016","journal-title":"Nanomed-Nanotechnol"},{"issue":"3","key":"10.1016\/j.biomaterials.2018.08.013_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2011.01.006","article-title":"Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends","volume":"152","author":"Polat","year":"2011","journal-title":"J. Contr. Release"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2018.08.013_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2011.10.031","article-title":"Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation","volume":"422","author":"Choi","year":"2012","journal-title":"Int J Pharmaceut"},{"issue":"11","key":"10.1016\/j.biomaterials.2018.08.013_bib33","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1021\/mp500277g","article-title":"Peptide-chaperone-directed transdermal protein delivery requires energy","volume":"11","author":"Ruan","year":"2014","journal-title":"Mol Pharmaceut"},{"issue":"1","key":"10.1016\/j.biomaterials.2018.08.013_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-3659(98)00182-5","article-title":"Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing","volume":"59","author":"Masson","year":"1999","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2018.08.013_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2013.10.007","article-title":"Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers","volume":"173","author":"Chen","year":"2014","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.biomaterials.2018.08.013_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1039\/C3TB21353F","article-title":"Development of an efficient transdermal drug delivery system with TAT-conjugated cationic polymeric lipid vesicles","volume":"2","author":"Wang","year":"2014","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.biomaterials.2018.08.013_bib37","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/mp200594z","article-title":"Identification of a novel skin penetration enhancement peptide by phage display peptide library screening","volume":"9","author":"Kumar","year":"2012","journal-title":"Mol Pharmaceut"},{"issue":"15","key":"10.1016\/j.biomaterials.2018.08.013_bib38","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1016\/j.biomaterials.2014.01.052","article-title":"The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine","volume":"35","author":"Ookubo","year":"2014","journal-title":"Biomaterials"},{"issue":"38","key":"10.1016\/j.biomaterials.2018.08.013_bib39","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1073\/pnas.1016152108","article-title":"Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer","volume":"108","author":"Hsu","year":"2011","journal-title":"P Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2018.08.013_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijpharm.2009.06.027","article-title":"Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome","volume":"380","author":"Gillet","year":"2009","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.biomaterials.2018.08.013_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jphotobiol.2013.07.014","article-title":"Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo","volume":"127","author":"Liu","year":"2013","journal-title":"J. Photochem. Photobiol., B"},{"issue":"92","key":"10.1016\/j.biomaterials.2018.08.013_bib42","doi-asserted-by":"crossref","first-page":"75636","DOI":"10.1039\/C5RA13830B","article-title":"Enhanced corneal permeation of coumarin-6 using nanoliposomes containing dipotassium glycyrrhizinate: in vitro mechanism and in vivo permeation evaluation","volume":"5","author":"Guo","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.biomaterials.2018.08.013_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2017.02.022","article-title":"Identification of novel B-Raf(V600E) inhibitors employing FBDD strategy","volume":"132","author":"Wang","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.08.013_bib44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1944","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.biomaterials.2018.08.013_bib45","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2147\/IJN.S156412","article-title":"Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study","volume":"13","author":"Abu Hashim","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2018.08.013_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Contr. Release"},{"issue":"39","key":"10.1016\/j.biomaterials.2018.08.013_bib47","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1021\/acs.langmuir.5b02797","article-title":"Lipid-peg conjugates sterically stabilize and reduce the toxicity of phytantriol-based lyotropic liquid crystalline nanoparticles","volume":"31","author":"Zhai","year":"2015","journal-title":"Langmuir"},{"issue":"5","key":"10.1016\/j.biomaterials.2018.08.013_bib48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.drudis.2016.01.004","article-title":"Cubosomes: remarkable drug delivery potential","volume":"21","author":"Karami","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2018.08.013_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2017.12.023","article-title":"Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate","volume":"271","author":"Rajan","year":"2018","journal-title":"J. Contr. Release"},{"issue":"13","key":"10.1016\/j.biomaterials.2018.08.013_bib50","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2018.08.013_bib51","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/10717544.2017.1326539","article-title":"Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies","volume":"24","author":"Salah","year":"2017","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.08.013_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1208\/s12249-012-9904-2","article-title":"Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers","volume":"14","author":"Duangjit","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.biomaterials.2018.08.013_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1248\/bpb.b13-00576","article-title":"Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam","volume":"37","author":"Duangjit","year":"2014","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.08.013_bib54","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/01932690903224862","article-title":"Preparation and in vitro skin permeation of cubosomes containing hinokitiol","volume":"31","author":"Kwon","year":"2010","journal-title":"J. Dispersion Sci. Technol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.08.013_bib55","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/mp500789h","article-title":"Role of the Na+\/K+-ATPase beta-subunit in peptide-mediated transdermal drug delivery","volume":"12","author":"Wang","year":"2015","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.biomaterials.2018.08.013_bib56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejmech.2012.12.054","article-title":"Transdermal delivery of human epidermal growth factor facilitated by a peptide chaperon","volume":"62","author":"Ruan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2018.08.013_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.12.006","article-title":"Peptides as skin penetration enhancers: mechanisms of action","volume":"199","author":"Kumar","year":"2015","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2018.08.013_bib58","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/mp300667p","article-title":"Effect of cationic cyclopeptides on transdermal and transmembrane delivery of insulin","volume":"10","author":"Chang","year":"2013","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.biomaterials.2018.08.013_bib59","article-title":"Nanoparticle elasticity directs tumor uptake","volume":"9","author":"Guo","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218305672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218305672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:35:13Z","timestamp":1758904513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961218305672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":59,"alternative-id":["S0142961218305672"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.08.013","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}